Compare · AGL vs NIVF
AGL vs NIVF
Side-by-side comparison of agilon health inc. (AGL) and NewGenIvf Group Limited (NIVF): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AGL and NIVF operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- AGL is the larger of the two at $1.61B, about 458.7x NIVF ($3.5M).
- Over the past year, AGL is up 214.4% and NIVF is down 99.8% - AGL leads by 314.3 points.
- AGL has been more active in the news (8 items in the past 4 weeks vs 7 for NIVF).
- AGL has more recent analyst coverage (25 ratings vs 0 for NIVF).
PerformanceAGL+214.43%NIVF-99.83%
2025-08-26+0.00%2026-08-25
- Company
- agilon health inc.
- NewGenIvf Group Limited
- Price
- -
- -
- Market cap
- $1.61B
- $3.5M
- 1M return
- -2.54%
- -46.10%
- 1Y return
- +214.43%
- -99.83%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 8
- 7
- Recent ratings
- 25
- 0
AGL
agilon health inc.
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Long Beach, California.
Latest AGL
- agilon health to Participate in Upcoming Conferences
- Chief Accounting Officer Gertsch Timothy covered exercise/tax liability with 17 shares, decreasing direct ownership by 0.12% to 14,152 units (SEC Form 4) (withholding tax)
- Amendment: SEC Form SCHEDULE 13G/A filed by agilon health inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by agilon health inc.
- agilon health upgraded by Citigroup with a new price target
- SEC Form 10-Q filed by agilon health inc.
- agilon health inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Chief Legal Officer Zamore Denise covered exercise/tax liability with 37 shares, decreasing direct ownership by 0.06% to 66,075 units (SEC Form 4) to satisfy withholding tax
- agilon health downgraded by Citigroup with a new price target
- agilon health inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
Latest NIVF
- SEC Form F-1 filed by NewGenIvf Group Limited
- SEC Form 3 filed by new insider Lee Sze Mun
- SEC Form 6-K filed by NewGenIvf Group Limited
- SEC Form 4 filed by Chairman & CEO Siu Wing Fung Alfred
- SEC Form 4 filed by Chief Marketing Officer Fong Hei Yue Tina
- SEC Form 6-K filed by NewGenIvf Group Limited
- NewGenIVF Completes Exchange of Convertible Notes with Institutional Investor
- SEC Form 6-K filed by NewGenIvf Group Limited
- SEC Form 6-K filed by NewGenIvf Group Limited
- NewGen Provides Update on K25.ai Investment and Strengthened Financial Position